Commerce & Finance Law Offices has in-depth experience across the range of private equity transactions, assisting clients throughout the entire financing process from a company’s establishment to its IPO, including angel, venture capital and strategic investments. In Beijing, Xiaoman Zhang has a strong track record handling domestic and overseas IPOs, M&A, and material assets restructuring. Also in Beijing, Xinyang Zhang is a specialist in the Chinese new economy and has a broad sector focus that spans AI, e-commerce and cultural entertainment.
Testimonials
Collated independently by Legal 500 research team.
‘The team has been focusing on investment and financing and IPO listing business in the medical industry for a long time, and is especially good at dealing with legal issues encountered in the investment and financing process from the perspective of listing compliance.’
‘The team is very commercially aware, has a high degree of integration in the upstream and downstream of the industry, quickly identifies important legal issues and conducts relevant legal research, and can mobilize resources within the firm to provide multi-dimensional legal services.’
‘The team is constantly improving and growing, and provide IPO, mergers and acquisitions and other services, have a high level of matching and understanding for subsequent exits in the early stage of investment, and provide relatively complex legal services.’
‘I have cooperated with Zhang Xinyang's lawyer team of Commerce & Finance Law Firm. Zhang's team represented us in some minority equity investmenttransactions. Attorney Zhang himself has rich experience, can respond quickly to complex and difficult issues, and provide practical promotion plans.’
‘Timely and professional.’
‘The team is quite familiar with the red-chip business, and understands the tax compliance and other matters involved in the process of building a red-chip structure.’
Key clients
- Youshan Capital
- GL Gyn Investment L.P
- Lake Bleu Capital
- Keep Inc.
- Hesai Technology
- Fiture Inc.
- Meituan - Angular Capital Hong Kong Limited
- Meituan Dianping
- Shuimu Youpin Limited
- Hopu Investment
- Zhuhai Trinomab Biotechnology Co., Ltd.
- IASO Biologics Inc.
- Transcendence Capital
- GL Capital (“Hangzhou Hengmei Food Technology”)
- DataGrand Technology (Shanghai) Co., Ltd.
- Singularity Systems Limited
- China Life
- Suzhou MicroPort Argus Medical Corp.
- GL Capital (“Shanghai Desano Pharmaceutical”)
- Beijing Surgerii Technology Co., Ltd.
- GL Capital (“Zhejiang Peptites Biotech Co.,Ltd”)
- Xiaomi
- Shanghai Shenzhi Information Technology Co., Ltd.
- DataMesh
- Mech-Mind (Beijing) Robotics Technologies Ltd.
- Gongqingcheng Ziniu Growth Investment Management Partnership
- Dongfanghonghu (Beijing) Technology Co., Ltd.
- Shanghai Chatail Information Technology Co., Ltd.
- Jinfeng Borun (Xiamen) Equity Investment Partnership
- GL Hospital Investment III L.P
- Shenzhen Zhiyuan Biological Medicine Co. Ltd.
- Ningbo Maihan Investment Management Co., Ltd.
- Beijing Century Hong Shui Hospital Management Ltd.
- Hesai Technology
- Guizhou Fengji Ecological Agriculture Technology Co., Ltd.
- DataGrand
- Chengdu Longteng Water Resources Development Co., Ltd.
- Hongjing Drive
- TopGear
- Yangtze Industry Investment Fund Management Co., Ltd.
- Lake Bleu Capital
- Modern Farming(Group)Co.,Ltd.
- 3H Health
- Nuwacell Biotechnologies Co., Ltd.
- Hongtai Aplus
- CTC Capital
Work highlights
- Assisted Hesai Tech with round D financing, obtain more than $370million of financing.
- Acted as Mech-Mind's corporate counsel, completing its C+ series financing projects, with a total amount of approximately ¥1bn.
- Acted for Fengji Group on its $600m financing.